Core Laboratories (NYSE:CLB) Announces Quarterly Earnings Results

Core Laboratories (NYSE:CLB) released its earnings results on Wednesday. The oil and gas company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01, Briefing.com reports. Core Laboratories had a net margin of 5.44% and a return on equity of 15.42%. The firm had revenue of $130.58 million for the quarter, compared to analyst estimates of $132.85 million. During the same period last year, the firm earned $0.23 EPS. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. Core Laboratories updated its Q3 2024 guidance to 0.230-0.270 EPS and its Q3 guidance to $0.23-0.27 EPS.

Core Laboratories Stock Down 1.3 %

CLB traded down $0.32 during trading on Friday, hitting $24.03. 23,225 shares of the company’s stock were exchanged, compared to its average volume of 452,440. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68. The business’s 50 day moving average is $19.76 and its two-hundred day moving average is $17.39. Core Laboratories has a fifty-two week low of $13.82 and a fifty-two week high of $27.94. The stock has a market cap of $1.13 billion, a P/E ratio of 27.68, a PEG ratio of 1.39 and a beta of 2.41.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 26th. Shareholders of record on Monday, August 5th will be issued a dividend of $0.01 per share. The ex-dividend date is Monday, August 5th. This represents a $0.04 annualized dividend and a yield of 0.17%. Core Laboratories’s payout ratio is 4.55%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Piper Sandler cut their target price on shares of Core Laboratories from $18.00 to $17.00 and set a “neutral” rating on the stock in a research report on Monday, July 15th. Bank of America lowered their price objective on shares of Core Laboratories from $16.00 to $15.00 and set an “underperform” rating for the company in a research note on Monday, July 15th. StockNews.com lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Wednesday, July 10th. Finally, Stifel Nicolaus lifted their price objective on shares of Core Laboratories from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, April 26th. Three investment analysts have rated the stock with a sell rating and two have assigned a hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $17.50.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.